Sensible Biotechnologies
$3.0M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Sensible Biotechnologies is currently valued at N/A as of November 30, 2024. The company has raised a total of $13.8M in funding.
Investment Perspective
Sensible Biotechnologies's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Sensible Biotechnologies Worth in 2025?
As of 2025, Sensible Biotechnologies is valued at N/A, based on the company's Seed Round funding round in November 30, 2024. This valuation positions Sensible Biotechnologies as one of the leading private companies in the sector.
Sensible Biotechnologies Valuation History
Sensible Biotechnologies's funding history demonstrates steady growth and investor confidence.
How Sensible Biotechnologies Valuation is Determined
Private company valuations like Sensible Biotechnologies's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Sensible Biotechnologies Valuation FAQs
Is Sensible Biotechnologies profitable?
Sensible Biotechnologies has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Sensible Biotechnologies's valuation compare to competitors?
Sensible Biotechnologies is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Sensible Biotechnologies IPO?
Sensible Biotechnologies has not announced plans for an initial public offering. Until an IPO, investors can access Sensible Biotechnologies shares through secondary market platforms.